Swep Bio, Inc. filed a Form D with the Securities and Exchange Commission on 2026-10-29.
Swep Bio, Inc. filed a Form D notice of an exempt securities offering with the SEC on October 29, 2026. The filing reports $2.50M sold. Its industry group is Biotechnology. It names Goran Dolsten (Executive Officer, Director), Karl Berglund (Executive Officer, Director), Lovisa Backemar (Director) (SEC Form D, October 29, 2026).
Selling to Swep Bio, Inc.? See who runs it and how to reach them, plus this week's 44 other newly funded companies.
Is this your company?
Sell to companies like Swep Bio, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-10-29 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Swep Bio, Inc.
Free to see. No signup.
More on the people and the money behind Swep Bio, Inc., from the filings we hold.
Biotechnology raises by companies based in New York, filed within 90 days of this one, largest first.
Get an email when Swep Bio, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Swep Bio, Inc. raises, hires or launches. No email unless you switch it on.
Watch Swep Bio, Inc. →Get the full cited report on Swep Bio, Inc.
What the filing shows about Swep Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Swep Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Swep Bio, Inc.'s address as 7 Rochambeau Road, Scarsdale, NY 10583.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Swep Bio, Inc. is a registered filer with the SEC (CIK 2159106) and has filed since 2026-10-29. 1 filing is on record, the latest on 2026-10-29.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Swep Bio, Inc.'s Form D of 2026-10-29 names Goran Dolsten, Karl Berglund and Lovisa Backemar as its officers, directors or promoters.
Its new offerings report $2.50M sold across 1 offering, as its own filings state.
Trailing twelve months. 766 filings in Biotechnology, totalled by week. The dot is this raise, $2.50M, on the same scale — one filing against the whole group's total, so it sits low by construction.
No amounts other than ordinary course employment compensation are being paid to officers and directors.
Goran Dolsten is named as Executive Officer and Director on the Form D that Swep Bio, Inc. filed with the SEC on 29 October 2026, one of 3 people that filing names.
Karl Berglund is named as Executive Officer and Director on the Form D that Swep Bio, Inc. filed with the SEC on 29 October 2026, one of 3 people that filing names.
Lovisa Backemar is named as Director on the Form D that Swep Bio, Inc. filed with the SEC on 29 October 2026, one of 3 people that filing names.
3 people named on the filing — 2 holding an executive role and 1 as a director only.
Named as of the 2026-10-29 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Swep Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Swep Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Swep Bio, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Swep Bio, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Swep Bio, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Swep Bio, Inc.. With no account yet, you sign up free and land on the result.
On these lists: New York raises, week of 2026-10-26 · Biotech raises, week of 2026-10-26 · Biotech raises in New York
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/swep-bio-inc-form-d-000001